Log in to save to my catalogue

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2582277073

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Tumor heterogeneity is predicted to confer inferior clinical outcomes, however modeling heterogeneity in a manner that still represents the tumor of origin remains a formidable challenge. Sequencing technologies are limited in their ability to identify rare subclonal populations and predict response to the multitude of available treatments for pati...

Alternative Titles

Full title

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2582277073

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2582277073

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.10.15.464556